Finland· FI-REL-REL4520
Orelox
A cefpodoxime product containing cefpodoxime proxetil, registered in Finland by sanofi-Aventis Oy. The same ATC class is registered in 6 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Cefpodoxime is registered in 6 of 19 countries.
Countries holding a registration under ATC J01DD13 (cefpodoxime), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Cefpodoxime · ATC J01DD13
6 / 19 countries
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of cefpodoxime costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.33 in Italy to $8.39 in Switzerland — a ×2.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefpodoxime · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$8.39
- IT Italy$3.33
The record
At a glance
Fimea (Finland)- Active substance
- Cefpodoxime proxetil
- Manufacturer
- sanofi-Aventis Oy
- Country
- Finland (FI)
- ATC code
- J01DD13
- ATC class
- Cefpodoxime
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
113 interactions on record for cefpodoxime.
Graded by severity as the source publishes them — 45 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefpodoxime · interactions on record
113 records
- 45 moderate
- 68 info
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefpodoxime in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCefpodoxime ProxetilAscend Laboratories, LLC
- CzechiaFOREXOAlkaloid - INT d.o.o., Ljubljana - Črnuče
- FranceCEFPODOXIME ARROW ENFANTS ET NOURRISSONS 40 mg/5 ml, poudre pour suspension buvableARROW GENERIQUES
- GermanyCefpoBasics Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Bulgaria · Сефпотек
- Germany · Cefpo, Cefpodoxim Ratiopharm
- France · Cefpodoxime Arrow Lab, Cefpodoxime Enfants Et Nourrissons Teva
- Greece · Orebus
- Italy · Cefodox, Cefodox Bambini
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d36c21e-bd7d-4be1-88fe-60c1e9020506 GET /v1/drugs/3d36c21e-bd7d-4be1-88fe-60c1e9020506?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.4",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "g",
"strength": "200 mg",
"atc_label": "kefpodoksiimi",
"ma_number": "12395",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL4520",
"authorised_at": "1997-03-24"
}See everything about cefpodoxime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.